Appraisal of the efficacy of SP-IPTP in Aminu Kano teaching hospital – impact on maternal anaemia, malaria parasitaemia and clinical malaria in pregnancy.
Background: Sulphadoxine-pyrimethamine (SP) intermittent preventive treatment in pregnancy (IPTp), is the malaria prophylaxis that is recommended in malaria endemic areas. Increasing reports of resistance to SP across the globe, make appraisal of its efficacy to be necessary in health facilities that use it.
Objective: To determine the efficacy of SP – IPTp in the prevention of malaria in pregnancy using Proguanil chemoprophylaxis as the gold standard, in Aminu Kano Teaching Hospital, Kano, Nigeria.
Methods: In this prospective study, 300 primigravid women were enrolled and assigned by block randomization to SP – IPTp (cases) or proguanil chemoprophylaxis (control) group. Each group consisted of 150 women. Study variables of interest were packed cell volume (PCV) at recruitment and at 34 weeks gestation, peripheral malaria parasitaemia, severe anaemia at 34 weeks gestation, and the frequency of clinical malaria during the study period in the two groups. The data obtained were recorded using tables. Students't-test, Z-test and chi-square test were used to compare means and proportions respectively for statistically significant differences, setting the level of significance at P < 0.05.
Results: There was statistically significant increase in the PCV between recruitment and at 34 weeks in each group (P < 0.05), but there was no statistically significant difference in the PCV, peripheral malaria parasitaemia and frequency of clinical malaria between the two groups at 34 weeks gestation (P > 0.05).
Conclusion: SP-IPTp has similar effectiveness as proguanil chemoprophlaxis. SP-IPTp is still effective in the prevention of malaria in pregnancy at Aminu Kano Teaching Hospital.
Keywords ; Sulphadoxine-pyrimethamine, proguanil, malaria, pregnancy.
The entire contents of the Tropical Journal of Obstetrics and Gynaecology are protected under Indian and international copyrights. The Journal, however, grants to all users a free, irrevocable, worldwide, perpetual right of access to, and a license to copy, use, distribute, perform and display the work publicly and to make and distribute derivative works in any digital medium for any reasonable non-commercial purpose, subject to proper attribution of authorship and ownership of the rights. The journal also grants the right to make small numbers of printed copies for their personal non-commercial use.
This journal content is distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.